Researchers tested combining mesenchymal stem cell therapy with a GHRH receptor analog (similar to Growth-1295) for treating dangerous brain swelling after stroke. The combination therapy worked by modulating water channels (AQP4) and cellular energy systems to reduce fatal post-stroke edema. This suggests GHRH analogs could be valuable adjunctive treatments alongside conventional stroke therapies. The study addresses a critical unmet need since current stroke treatments fail to manage cerebral edema effectively.
For your business
New research shows GHRH analogs like Growth-1295 may help resolve life-threatening brain swelling after stroke by targeting water regulation pathways.